All news

U.S. Physical Therapy adds Myra Davis to board

Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash

U.S. Physical Therapy (USPH) has appointed Myra Davis to its board effective October 1, 2026, adding healthcare technology and governance expertise. Analysts carry a consensus target price of USD 98.25 for USPH, implying significant upside from the current market quote. The company reported an 8.50% year-over-year increase in Q2 2026 revenue, while net income and cash holdings declined.

Read original source

USPH company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.